Wang, J.; Chang, H.; Su, M.; Qiao, Y.; Sun, H.; Zhao, Y.; Zhang, S.; Shan, C.
Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma. Int. J. Mol. Sci. 2022, 23, 4583.
https://doi.org/10.3390/ijms23094583
AMA Style
Wang J, Chang H, Su M, Qiao Y, Sun H, Zhao Y, Zhang S, Shan C.
Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma. International Journal of Molecular Sciences. 2022; 23(9):4583.
https://doi.org/10.3390/ijms23094583
Chicago/Turabian Style
Wang, Jiyan, Hongkai Chang, Meng Su, Yaya Qiao, Huanran Sun, Yongshan Zhao, Shuai Zhang, and Changliang Shan.
2022. "Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma" International Journal of Molecular Sciences 23, no. 9: 4583.
https://doi.org/10.3390/ijms23094583
APA Style
Wang, J., Chang, H., Su, M., Qiao, Y., Sun, H., Zhao, Y., Zhang, S., & Shan, C.
(2022). Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma. International Journal of Molecular Sciences, 23(9), 4583.
https://doi.org/10.3390/ijms23094583
